Postoperative use of rFVIIa by continuous infusion in a haemophilic boy

Continuous infusion of coagulation factor concentrates has proved to be safe and effective. Because rFVIIa (NovoSeven®) is a very expensive product and very frequent doses are needed, continuous infusion is expected to be highly cost‐effective. The postoperative use of continuous infusion of rFVIIa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Haemophilia : the official journal of the World Federation of Hemophilia 1999-03, Vol.5 (2), p.135-138
Hauptverfasser:	LORENZO, J. I., MONTORO, J. M., AZNAR, J. A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent continuous infusion Drug Stability Factor VIIa - therapeutic use factor VIII inhibitors haemophilia surgery haemophilia therapy Hemophilia A - drug therapy Humans Infusions, Intravenous Male pharmacokinetics Postoperative Care - methods recombinant FVIIa Recombinant Proteins - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!